Answer
Rivaroxaban selectively and directly inhibits factor Xa, interrupting the intrinsic and extrinsic coagulation pathways to inhibit thrombin formation and clot development, without directly inhibiting thrombin or having demonstrated effects on platelets.
Sources for this answer
- Xarelto 10 mg film-coated tabletsBayer plc · emc · SmPC §5.1 Pharmacodynamic properties · Version 36Document updated
Sources checked